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Objective To compare short-term effects of fine
particles (PM2.5; aerodynamic diameter <2.5 mm) from
different sources on the blood levels of markers of
systemic inflammation.
Methods We followed a panel of 52 ischaemic heart
disease patients from 15 November 2005 to 21 April
2006 with clinic visits in every second week in the city
of Kotka, Finland, and determined nine inflammatory
markers from blood samples. In addition, we monitored
outdoor air pollution at a fixed site during the study
period and conducted a source apportionment of PM2.5
using the Environmental Protection Agency’s model EPA
PMF 3.0. We then analysed associations between levels
of source-specific PM2.5 and markers of systemic
inflammation using linear mixed models.
Results We identified five source categories: regional
and long-range transport (LRT), traffic, biomass
combustion, sea salt, and pulp industry. We found most
evidence for the relation of air pollution and
inflammation in LRT, traffic and biomass combustion; the
most relevant inflammation markers were C-reactive
protein, interleukin-12 and myeloperoxidase. Sea salt
was not positively associated with any of the
inflammatory markers.
Conclusions Results suggest that PM2.5 from several
sources, such as biomass combustion and traffic, are
promoters of systemic inflammation, a risk factor for
cardiovascular diseases.
INTRODUCTION
An association between ambient particulate matter
(PM) and cardiovascular health has been established
in many studies.1 2 Low-level inflammation plays a
key role in the development of cardiovascular dis-
eases, such as atherosclerosis,3 while acute changes
in inflammatory status are associated with the vul-
nerability of atherosclerotic plaque.1 Therefore, it
has been hypothesised that increased systemic
inflammation due to inhalation of PM may explain
the observed associations between daily ambient PM
and cardiovascular mortality and hospitalisations.
Indeed, daily levels of outdoor particulate air pollu-
tion have been reported to be associated with the
concentration of inflammatory markers.1
Ambient air fine particles (PM2.5; particles
<2.5 mm in aerodynamic diameter) are a mixture
of numerous components originating from different
sources and atmospheric processes. Association
between black carbon particles, an indicator for
combustion derived particles, and cardiopulmonary
morbidity and mortality has been concluded in a
systematic review by Janssen et al.4 However, black
carbon per se may not be responsible for the
observed health effects, but may merely act as an
indicator of harmful PM constituents originating
from combustion processes. Many epidemiological
studies have reported particles originating from
combustion of fossil fuels, including road traffic, to
be associated with cardiopulmonary health, but
fewer studies have included particles originating
from biomass combustion, another source of black
carbon.5 One important source category is formed
by long-range transport (LRT) of particles. The
source is comprised of secondary aerosols, formed
over a longer time in the atmosphere, and is typic-
ally characterised by sulfate. Sulfate has been asso-
ciated with cardiovascular and respiratory health
effects in short-term epidemiological studies.6 In
general, there is a lack of epidemiological studies
comparing the strength of association between dif-
ferent sources and health.
We have previously reported that even low daily
levels of PM2.5, typical for smaller cities in Europe
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What this paper adds
▸ Ambient fine particulate matter (PM2.5;
aerodynamic diameter <2.5 mm) has adverse
effects on cardiovascular health.
▸ Systemic inflammation has been proposed to
be one mechanism linking inhaled PM2.5 with
cardiovascular events.
▸ Some epidemiological studies suggest that
PM2.5 from traffic has an effect on
inflammation, but the influence of PM2.5 from
other sources is poorly known.
▸ In this study, PM2.5 from several sources was
associated with systemic inflammation.
▸ Multitude of harmful sources of particulate air
pollution makes abatement of health effects
more challenging and more expensive, because
legislation and air pollution control methods
cannot focus on any particular source type.
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and North America, may increase systemic inflammation among
elderly subjects with coronary heart disease.7 In this paper, we
exploit the same health study conducted in Kotka, Finland, and
evaluate associations between the daily concentrations of source-
specific PM2.5 and the levels of inflammatory markers in blood.
METHODS
Study design
We recruited 52 elderly persons with clinically stable ischaemic
heart disease (IHD) for the study (see online supplementary
figure S1). Participants lived in the city centre of Kotka (55 000
inhabitants) in Finland. We followed the study participants
every second week between 15 November 2005 and 12 May
2006. However, a significant air pollution episode, caused by
large wildfires in Eastern Europe, occurred in Eastern Finland at
the end of April 2006. Because these exceptionally high air pol-
lution levels during the episode did not represent normal expos-
ure, we excluded the end of the measurement period from the
data. Therefore the final data comprised measurements con-
ducted between 15 November 2005 and 21 April 2006; the
number of repeated visits ranged from 3 to 11 (medium=5)
depending on the number of visits cancelled (eg, because of
symptoms of influenza). We scheduled clinical visits on the same
weekday and at the same time of the day (for 96% of the parti-
cipants the variability was ± 1h) to minimise potential influence
of weekly and circadian variation. The study protocol was based
on the AIRGENE study8 and the recruitment process has been
described previously by Huttunen et al.7 The main inclusion cri-
teria for the study subjects were IHD diagnosed by a physician,
being a non-smoker, and age 35–80 years. We excluded partici-
pants with diagnosed chronic diseases with a strong inflamma-
tory component. Inflammatory diseases leading to exclusion
were Crohn’s disease, colitis ulcerosa, rheumatoid arthritis,
haemophilia and HIV. Persons who had had myocardial infarc-
tion, surgery, angioplasty, balloon angioplasty, bypass operation
or infection within 6 months were also excluded. We received
ethics approval from the ethics committee of the Kymenlaakso
Hospital District. In addition, all study subjects signed a written
informed consent.
Clinical measurements
At the first visit, we collected information on the health status,
medication intake and lifestyle factors of the study subjects with
a baseline questionnaire. During each clinical visit, we collected
venous blood samples in EDTA and citrate plasma tubes for the
determination of the inflammatory markers. We processed the
blood samples for further analysis within 0.5 h. We centrifuged
the samples at 4°C for 15 min and stored plasma at −70°C until
measurement of the indicators of systemic inflammation.
We analysed the cytokines interleukin (IL)-1β, IL-6, IL-8 and
IL-12, and interferon (IFN) γ from the EDTA-plasma with an
immunologic ELISA method (OptEIA, Becton Dickinson, San
José, California, USA) at the Department of Environmental
Health, National Institute for Health and Welfare (Kuopio,
Finland). Cytokine analysis was optimised with in-house titra-
tion experiments; the minimum detectable level was determined
for each cytokine by defining the concentration above two SDs
of the average optical densities of 20 replicates of the zero
standard (IL-1β, 14 pg/mL; IL-6, 2 pg/mL; IL-8, 1 pg/mL; IL-12,
5 pg/mL; and IFNγ, 4 pg/mL). For cytokines IL-1β, IL-6 and
IFNγ, the proportion of samples below the detection limit was
considered too high (42–70%) to conduct reliable statistical ana-
lyses. Thus, only the results for IL-8 and IL-12 are presented in
this paper.
We analysed high-sensitive C-reactive protein (CRP), fibrino-
gen (FB), white blood cell (WBC) count and myeloperoxidase
(MPO) at the Kymenlaakso Hospital Services (Laboratory of
Clinical Chemistry, Carea, Kotka, Finland). CRP was analysed
from EDTA-plasma with an immunoturbidimetric method
(Sentinel CRP Vario List No. 6K26-02), and FB from citrate-
plasma with a chromogenic method. WBC counting was per-
formed by an automatic haematological analyser (CellDyn
4000, Abbott), and levels of MPO were determined by ELISA
(MPO Elisa Kit, Immunodiagnostik) using the instrument
Multiscan Ex (Thermolabsystems). Detection limits for the CRP,
FB and MPO analyses were <0.1 mg/mL, <0.5 g/L and
1.4 ng/mL, respectively. Values below the detection limit were
included as such in the data for IL-8 and IL-12, and treated as
missing values for CRP, WBC and FB.
Air pollution data and meteorological parameters
Before the beginning of the study period, we set up a measure-
ment station to monitor general air quality prevailing at the
study area. The station was located in a schoolyard in the city
centre, and was surrounded by three-storey apartment buildings
at a distance of 15–30 m. A major road leading from the city
centre to the surrounding areas was located 1000 m west from
the station. All study participants lived within a distance of
1.6 km from the fixed outdoor air pollution monitoring site.
The sample intakes were placed about 5–6 m above the level of
the nearest street.
We measured particle number concentration (PNC) with a
condensation particle counter (CPC 3022, particles >20 nm in
aerodynamic diameter), and nitrogen oxide (NO) and nitrogen
dioxide (NO2) with the chemiluminescence method (AC-30M
Environment, Poissy, France). We collected 24 h outdoor PM2.5
samples with an EPA-well impactor ninety-six (WINS) sampler,9
which operated at a flow rate of 16.7 l/min. We used prewashed
(methanol and deionised) polytetrafluoroethylene (PTFE) filters
(diameter 47 mm, pore size 3 mm, type FS, Millipore Ireland,
Carrigtwohill, Ireland) to collect the samples. Filters were
changed daily at noon (86% of filters were collected between
10:00 and 14:00) and 24 h averages were calculated from the
continuous data from noon to noon.
We weighed the PTFE filters with a Mettler M3 microbalance
(Mettler Instumente, Zurich, Switzerland) before and after sam-
pling. Temperature and relative humidity in the weighing room
ranged from 22.6 to 23.8°C and from 10.1 to 26.3%, respect-
ively. We stabilised the filters inside a laminar flow bench for
about 30 min before weighing, and used the Electrical dischar-
ger (Mettler Toledo, HAUG, Leinfelden-Achterdingen,
Germany) and Po-210 (1U400 static master, NRD, Grand
Island, New York, USA) radioactive source to control the static
electricity. After weighing, we stored the samples in a freezer
(−20°C) until chemical analyses.
We determined the absorption coefficient (ABS), an indicator
of combustion derived particles, by measuring reflectance of the
PTFE filters from a EPA-WINS sampler with a smoke stain
reflectometer (Model M34D, Diffusion Systems, London, UK).
Reflectance of PM2.5 filters was transformed into an absorption
coefficient (a) according to ISO983510:
a ¼ A
2V




where A=loaded filter area (m2), V=sampled volume (m3),
R0=average reflectance of field blank filters and Rs=reflectance
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of the sampled filter. Absorption coefficients are expressed in
1/m×1/105. We used only one half of each PTFE filter in this
ABS measurement.
We used the other half of the filters to analyse a group of
selected ions with an ion chromatograph (DX500, Dionex
Corporation, Sunnyvale, California, USA). We analysed the
anions (Cl−, NO3
−, SO4
2− and oxalate) using an AS11 column
and 1–20 mM sodium hydroxide eluent with a flow rate of
1.5 mL/min, and the cations (Na+, NH4
+, K+, Mg2+ and Ca2+)
using a CS12 column and 20 mM methanesulfonic acid eluent
with a flow rate of 1.2 mL/min. In addition, we analysed mono-
saccharide anhydrides, including levoglucosan, using an
anion-exchange chromatograph coupled to an ion trap mass
spectrometer (Agilent Technologies SL, Santa Clara, California,
USA).11 Chemical analyses are described in more detail by
Aurela et al.12
The city of Kotka recorded meteorological parameters (air
temperature, relative humidity, barometric pressure and wind
direction) with an automatic weather station located at a dis-
tance of 1.5 km from the fixed outdoor measurement site.
Source apportionment
We conducted a source apportionment for PM2.5 using the EPA
PMF 3.0. model of the US Environmental Protection Agency.
Information on the source-apportionment analyses can be found
in the online supplementary material.
Statistical analyses
We performed statistical analyses using linear mixed models
with a random patient intercept and a compound symmetry
covariance structure in SAS V.9.2. Based on the distribution of
model residuals, we log transformed IL-12, IL-8, CRP and
MPO. Furthermore, we evaluated immediate and lagged air pol-
lution effects (up to 4 days lag). We defined lag 0 concentration
as the 24 h average concentration from noon of the previous
day to noon of the day of the clinic visit; lag 1 was defined as
the preceding 24 h period, and lags 2–4 accordingly.
We built first a confounder model without air pollutants sep-
arately for each inflammatory marker. We used penalised splines
(P-splines) in the additive mixed model framework to allow for
non-linear confounder-response functions,13 and used minimisa-
tion of Akaike’s information criteria method to select the shape
and lag of the confounder into the model. Long-term time
trend and apparent temperature (which contains temperature
and relative humidity) were included as confounders. In the first
step, we added a variable for long-term time trend in the model,
in either linear or non-linear form. In the second step, we chose
between lag 0 and the average of lags 1–3 for apparent tempera-
ture, testing again for the linearity of the effect. We tested both
compound symmetry and first-order autocorrelation structures
to confirm the applicability of the chosen correlation structure.
As sensitivity analyses, we evaluated the effect of extreme values
(>3 times the SD) on the results, and matched the lag-time of
temperature in the models with the lag-time of air pollution. We
present the associations as percentage changes of the outcome
mean per 1 mg/m3 increase in air pollutant concentration
together with 95% CIs.
RESULTS
Baseline characteristics of the study population are presented in
table 1. Fifty-two study participants had at least three valid
repeated visits, and the total number of clinical visits during the
5 months study period was 444. Mean concentrations of IL-12,
IL-8, CRP, FB, WBC and MPO were 474 pg/mL, 3.1 pg/mL,
2.3 mg/L, 3.1 g/L, 6.7×109/L and 76 mg/L, respectively.
Proportions of samples below the detection limit ranged from
1% for CRP to 7% for IL-8.
We identified five source categories in the PM2.5 in source
apportionment. Descriptive statistics for source specific PM2.5
and Spearman’s correlations (r) for air pollution and tempera-
ture are presented in table 2. The main source category was
regional and LRT (56% of the measured mass). The average
contributions of LRT, traffic, biomass combustion, sea salt and
pulp industry were 4.5, 0.6, 1.6, 0.1 and 1.0 mg/m3, respect-
ively. The model explained, on average, 99% of the variation in
measured PM2.5 concentration. The levels of PM2.5 from differ-
ent sources had mainly very weak positive correlations with
each other, and the highest correlation (r=0.56) was observed
between LRT and biomass combustion. Correlations between
sea salt and other sources were negative. Mean temperature
during the study period was −4.3°C, and it had moderate nega-
tive correlation with PM related to traffic and pulp industry.
Associations between the levels of source-specific PM2.5 and
the levels of inflammatory markers are presented in table 3.
Under the assumption of independent observations, we would
have expected six false statistically significant associations (5 out-
comes*4 lags*6 sources, α-level 0.05), but observed 11 (and one
borderline significant). We found the strongest, statistically sig-
nificant, association between traffic emissions and IL-12 at a lag
of 1 day. Biomass combustion and pulp industry were also posi-
tively associated with IL-12; for LRT the effect estimate was
borderline significant. Biomass combustion was also associated
with CRP and MPO at a 2-day lag, whereas pulp industry was
associated with MPO (lag 0), but not with CRP. LRT was asso-
ciated with both CRP and MPO at 1- and 2-day lags. Sea salt
had a strong negative association with IL-12 at lag 1 and with
IL-8 at lag 0.
Effect estimates for the 5-day average concentrations of the
source-specific PM2.5 are presented in figure 1. Concerning
Table 1 Baseline characteristics of the study population
(52 ischaemic heart disease patients)
Characteristic Value
Age, mean (years) (range) 71 (50–80)




Self reported history, n (%)
Myocardial infarction 25 (48)
Angina pectoris 31 (60)
Arrhythmia 26 (50)






Total cholesterol, mean (mmol/L) (SD) 4.2 (0.8)
High-density lipoprotein cholesterol, mean (mmol/L) (SD) 2.0 (3.0)
Medication, n (%)
Statins 43 (83)
Lipid-lowering medication 47 (90)
Antithrombotic medication 46 (88)
Regular use of β-blockers 42 (81)
Siponen T, et al. Occup Environ Med 2015;72:277–283. doi:10.1136/oemed-2014-102240 279
Environment
IL-12, we found the highest effect estimate again for traffic, but
it was not statistically significant. Also the association between
IL-12 and biomass combustion was only suggestive, but LRT
and biomass combustion showed a positive association with
CRP. For MPO, a suggestive evidence of association was
observed for biomass. PM2.5 from pulp industry was positively
associated with IL-12, but negatively with CRP and IL-8.
For comparison, the effect estimates for the 5-day average
concentrations calculated per interquartile increase of the
source-specific PM2.5 are presented for IL-12 and CRP in online
supplementary figure S4.
In general, we did not find substantial changes in the results,
when we excluded extreme concentrations (at maximum 50 mea-
surements per lag). However, more negative associations were
observed for sea salt. Associations between pulp industry and
inflammatory markers got mainly weaker, whereas negative
associations between sea salt and inflammatory markers strength-
ened when we matched the lag-time of source-specific PM2.5
with the lag time of temperature. Because of the relatively high
correlation (r=0.56) between LRT and biomass combustion, we
also run two-pollutant models. Effect estimates for LRT turned
out to be more robust for the adjustment (data not shown).
DISCUSSION
To our knowledge, this is the first epidemiological study to
evaluate associations between daily variation in source-specific
fine particulate air pollution and markers of systemic inflamma-
tion. In this panel study of elderly individuals with IHD, we
found significant positive associations between source-specific
PM2.5 and inflammatory markers CRP, IL-12 and MPO. The
strongest associations were observed for LRT, traffic emissions
and biomass combustion contributions to PM2.5. We also
Table 2 Descriptive statistics and Spearman’s correlations for air pollution and temperature (T)
Percentile Correlations
n Mean (±SD) 25th 50th 75th Max TRAF BIOM SALT IND PM2.5 ABS PNC T
LRT (mg/m3) 130 4.5 (±3.4) 1.7 4.3 6.0 17.4 0.16 0.56 −0.54 0.07 0.86 0.60 0.30 −0.11
TRAF (mg/m3) 130 0.6 (±0.4) 0.3 0.5 0.7 1.7 0.19 −0.07 0.14 0.25 0.44 0.84 −0.41
BIOM (mg/m3) 130 1.6 (±1.5) 0.5 1.1 2.2 7.4 −0.16 0.11 0.76 0.88 0.30 −0.15
SALT (mg/m3) 130 0.1 (±0.2) 0.01 0.02 0.06 1.2 0.21 −0.38 −0.22 −0.12 −0.02
IND (mg/m3) 130 1.0 (±1.0) 0.3 0.7 1.4 6.0 0.27 0.23 0.27 −0.41
PM2.5 (mg/m
3) 160 8.1 (±5.0) 4.5 6.8 10.0 27.6 0.82 0.40 −0.19
ABS (m−1×10−5) 131 1.5 (±0.9) 0.9 1.3 1.9 4.8 0.49 −0.23
PNC (cm−3) 155 6300 (±5100) 3100 4599 7937 29 332 −0.42
T (°C) 160 −4.3 (±6.1) −7.6 −2.8 0.3 7.3
ABS, absorption coefficient; BIOM, biomass combustion; IND, pulp industry; LRT, regional and long-range transport; PM2.5, particles <2.5 mm in aerodynamic diameter; PNC, particle
number concentration; SALT, sea salt; TRAF, traffic emissions.
Table 3 Associations of source-specific PM2.5 (fine particles, particles <2.5 mm in aerodynamic diameter) on inflammatory markers
Inflammatory
Lag
LRT TRAF BIOM SALT IND
marker % change (95% CI) % change (95% CI) % change (95% CI) % change (95% CI) % change (95% CI)
IL-12 0 1.60 (0.00 to 3.22) 0.73 (−12.3 to 15.46) 3.39 (0.19 to 6.71) −5.43 (−34.29 to 36.11) 3.81 (−0.64 to 8.46)
1 0.79 (−0.72 to 2.31) 17.97 (3.19 to 34.86) 3.46 (0.63 to 6.37) −29.98 (−48.71 to −4.41) 4.49 (−0.43 to 9.66)
2 0.26 (−1.14 to 1.68) 4.33 (−8.91 to 19.49) 1.24 (−1.83 to 4.42) 26.32 (−7.11 to 71.77) −1.16 (−7.60 to 5.72)
3 0.57 (−0.88 to 2.03) 14.28 (−0.81 to 31.68) 1.68 (−1.27 to 4.71) 10.21 (−17.92 to 47.99) 8.36 (0.57 to 16.75)
IL-8 0 0.64 (−1.66 to 2.98) −7.69 (−24.82 to 13.33) −0.60 (−5.13 to 4.15) −59.32 (−76.58 to −29.34) −5.36 (−11.69 to 1.42)
1 1.71 (−0.37 to 3.83) −0.29 (−18.28 to 21.65) 1.96 (−1.98 to 6.06) −18.19 (−47.15 to 26.63) −4.51 (−11.26 to 2.75)
2 0.88 (−1.07 to 2.87) 6.56 (−13.00 to 30.51) 2.57 (−1.66 to 6.97) −11.54 (−44.93 to 42.09) −4.88 (−13.30 to 4.37)
3 0.66 (−1.38 to 2.75) 9.27 (−10.59 to 33.53) 2.09 (−1.89 to 6.23) −15.93 (−45.22 to 29.03) 3.71 (−6.54 to 15.09)
CRP 0 0.40 (−2.32 to 3.19) 9.23 (−12.01 to 35.61) −1.85 (−6.92 to 3.48) 17.09 (−36.80 to 116.91) −1.19 (−7.86 to 5.97)
1 3.15 (0.75 to 5.60) 19.21 (−4.29 to 48.47) 4.40 (−0.16 to 9.17) −24.86 (−59.66 to 39.96) −5.86 (−12.80 to 1.63)
2 2.53 (0.32 to 4.78) 1.54 (−18.18 to 26.01) 6.14 (1.12 to 11.41) −14.74 (−47.69 to 38.99) −1.98 (−11.35 to 8.37)
3 1.63 (−0.74 to 4.06) 6.69 (−16.88 to 36.93) 1.82 (−2.80 to 6.65) −19.48 (−50.22 to 30.24) −8.85 (−19.03 to 2.62)
FB 0 −0.04 (−0.57 to 0.49) 0.28 (−4.39 to 4.95) 0.12 (−0.89 to 1.13) 8.76 (−1.67 to 19.19) −0.52 (−1.81 to 0.77)
1 0.29 (−0.20 to 0.77) −1.60 (−5.66 to 2.46) 0.39 (−0.46 to 1.24) −2.31 (−10.93 to 6.30) −0.30 (−1.64 to 1.05)
2 −0.04 (−0.51 to 0.42) 0.92 (−2.87 to 4.72) 0.01 (−0.93 to 0.94) −5.98 (−14.73 to 2.77) −1.32 (−3.01 to 0.38)
3 −0.31 (−0.78 to 0.15) 0.74 (−3.36 to 4.84) −0.17 (−1.09 to 0.75) −2.93 (−11.34 to 5.48) −0.52 (−2.41 to 1.38)
WBC 0 0.11 (−0.40 to 0.62) −1.19 (−5.08 to 2.70) 0.14 (−0.82 to 1.09) −1.34 (−12.34 to 9.66) 0.08 (−1.20 to 1.37)
1 0.16 (−0.27 to 0.58) −1.52 (−5.46 to 2.41) 0.02 (−0.82 to 0.85) 4.24 (−6.94 to 15.41) −1.17 (−2.61 to 0.27)
2 0.05 (−0.34 to 0.43) 1.45 (−2.35 to 5.25) 0.77 (−0.09 to 1.63) −4.78 (−13.35 to 3.79) 0.19 (−1.56 to 1.95)
3 −0.19 (−0.60 to 0.22) 2.97 (−1.26 to 7.20) 0.25 (−0.55 to 1.06) −2.21 (−10.77 to 6.34) −0.41 (−2.41 to 1.58)
MPO 0 0.88 (−0.08 to 1.84) 3.90 (−4.07 to 12.54) 1.25 (−0.62 to 3.15) −12.55 (−29.51 to 8.50) 2.95 (0.45 to 5.51)
1 1.08 (0.20 to 1.97) 3.13 (−4.81 to 11.73) 1.05 (−0.59 to 2.71) −8.57 (−26.46 to 13.67) 1.26 (−1.53 to 4.13)
2 0.80 (0.02 to 1.59) 3.96 (−3.71 to 12.24) 2.07 (0.31 to 3.86) −6.53 (−22.35 to 12.51) 1.36 (−2.31 to 5.16)
3 0.42 (−0.41 to 1.26) 3.74 (−5.02 to 13.30) 0.55 (−1.05 to 2.18) −13.01 (−26.37 to 2.78) −2.55 (−6.43 to 1.49)
Effect estimates calculated for 1 mg/m3 increase in source-specific PM2.5.
BIOM, biomass combustion; CRP, C-reactive protein; FB, fibrinogen; IL, interleukin; IND, pulp industry; LRT, regional and long-range transport; PM2.5, particles <2.5 mm in aerodynamic
diameter; MPO, myeloperoxidase; SALT, sea salt; TRAF, traffic emissions; WBC, white blood cell count.
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observed decreased levels of inflammatory markers in associ-
ation with PM2.5 rich in sea salt.
CRP is the most well-known inflammatory marker which is
commonly used in clinical tests to represent systemic inflamma-
tion in the human body. An increased level of CRP is predictive
of an elevated risk for future cardiovascular morbidity and mor-
tality.14 Particulate air pollution has been reported to be asso-
ciated with the levels of CRP in several studies.15–17 In this study,
we observed consistent associations between CRP and biomass
combustion as well as LRT. CRP has been reported to react to
changes in air pollution with a few days lag,15–17 which was also
true in our study. However, it is not well known how fast other
inflammatory markers react to changes in air pollution levels (or
in any other stressors). Reaction may occur immediately after
exposure and then disappear, but sometimes, for example, acute
phase proteins can induce a new delayed reaction of cytokines
after a few days. Therefore, we did not have any strong hypoth-
esis on the lag times of inflammation markers other than CRP.
Cytokine IL-12 is produced by macrophages and dendritic
cells, and it is suggested to enhance the development of athero-
sclerosis by stimulating T-cell recruitment into atherosclerotic
plaques.18 IL-12 was another marker of systemic inflammation
for which we found evidence of an air pollution effect: PM2.5
from LRT, biomass combustion and traffic were associated with
increased IL-12 concentrations in the blood of IHD patients.
MPO, a leucocyte enzyme, is stored in neutrophils and mono-
cytes, and is released by leucocyte activation and degranulation.
This has been proposed to be a risk marker for coronary artery
disease.19 20 In our study MPO was associated with PM2.5 from
LRT, biomass combustion and pulp industry.
Our study also included some inflammatory markers which
apparently were not affected by air pollution. For FB, IL-8 and
WBC we found no consistent associations with PM2.5 originat-
ing from any of the five sources. FB is a commonly used marker
of inflammation and increased risk of blood coagulation in clin-
ical medicine. Results from previous studies are inconclusive:
positive,21 22 negative23 and non-existent15 associations between
PM and FB have been reported.
WBC count has been considered to be a stable marker of vas-
cular inflammation, and a predictor of long-term cardiovascular
events.24 25 Some previous studies have associated short-term
increases in the levels of ambient PM with elevated numbers of
WBCs,26 27 whereas some other studies have found no evidence
of association.23
In southern Finland more than half of all ambient PM2.5 is
long-range transported air pollution. In our study, the propor-
tion of LRTwas 56%. In Helsinki, Finland, almost all of sulfate
and ammonium and more than half of nitrate are long-range
transported.28 In our study LRT was characterised, in addition
to sulfate and ammonium, by oxalate—an indicator of biomass
combustion, especially during the cold and low-solar radiation
wintertime when it is not formed by atmospheric processes.
Some of the biomass combustion particles were likely emitted
by nearby sources, whereas the rest came via regional and LRT,
but separation of these two is not unambiguous. Biomass com-
bustion correlated moderately with LRT.
Small-scale wood combustion as a primary or secondary
heating source in residential areas is common throughout
Finland. In the Helsinki metropolitan area, where nearly 80%
of households are connected to the district heating system, the
contribution of biomass combustion derived aerosol in PM2.5
has been estimated by Saarnio et al29 to be about 31–66% in
suburban areas and 18–29% in urban areas during the coldest
heating season (October–March). The higher proportion of PM
from biomass combustion in suburban areas reflected the higher
contribution of local residential wood combustion. In our study
20% of the explained PM2.5 was from biomass combustion,
which agrees well with the findings from the Helsinki metropol-
itan area.
It is noteworthy that fine particles from biomass combustion
were associated with CRP, IL-12 and MPO in our study. The
finding supports the recent review by WHO,6 where evidence
was found for an effect of particles from biomass combustion
on cardiovascular health. The review concluded that cardiovas-
cular effects of particles from biomass combustion may be com-
parable to those from traffic. The conclusion was supported by
those few short-term studies, which have compared in the same
set-up the associations of biomass and traffic-related PM2.5 with
daily cardiovascular mortality or hospitalisations.30 31
Vehicular traffic exhausts and stationary combustion processes
are major sources of fine particles. It has been suggested that in
urban areas traffic is also the most important source of ultrafine
particles,32 33 which have been associated with increased levels
of inflammation and coagulation markers in some studies.21 34
We did not have a specific indicator component for traffic emis-
sions, but in our source apportionment analysis, the factor
describing traffic emissions was characterised by high levels of
NO and PNC.
Figure 1 Estimated effect of 5-day
average source-specific PM2.5 (particles
<2.5 mm in aerodynamic diameter) on
inflammatory markers. Effect estimates
have been calculated as percentage
changes of the outcome mean per
1 mg/m3 increase in air pollutant
concentration together with 95% CIs.
BIOM, biomass combustion; CRP,
C-reactive protein; FB, fibrinogen; IL,
interleukin; IND, pulp industry; LRT,
regional and long-range transport;
MPO, myeloperoxidase; SALT, sea salt;
TRAF, traffic emissions; WBC, white
blood cell count.
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The mass portion of sea salt can vary depending on the
season. The proportion of sea salt from all measured fine parti-
cles in Kotka was 1% during our field measurements. Sea salt
concentrations were associated negatively with the levels of
inflammatory markers, and sea salt had a moderate negative cor-
relation with LRT. Based on back trajectories, LRT particles rich
in secondary sulfate are typically transported to Kotka from
central and Eastern Europe, whereas air masses containing sea
salt passed over cleaner sea areas.
In our previous study7 we evaluated associations between dif-
ferent PM size fractions and the concentrations of inflammatory
markers in blood. Given as percentage changes of outcome
mean per 1 mg/m3 increase in PM2.5 concentration, the strongest
associations between ambient PM2.5 and inflammatory markers
were found for CRP (2.6%; 95% CI 0.9% to 4.5%) and for
IL-12 (1.3%; 95% CI 0.3% to 2.4%). Here we studied the
effects of PM2.5 from different sources; the effect estimate
found for IL-12 was even higher for traffic-related PM2.5
(18.0%; 95% CI 3.2% to 34.9%) than for total ambient PM2.5.
In the case of CRP, the effect estimates for ambient PM2.5 were
clearly higher than for source-related PM2.5. Furthermore,
MPO was associated in the previous study with total PM2.5
(0.6%; 95% CI 0.05% to 1.2%). For MPO, effect estimates for
PM2.5 from LRT, biomass and pulp industry were somewhat
higher than those for total PM2.5.
A strength of this study is that exposure assessment is based
on data from the central measurement site located only a short
distance from the homes of the study participants. Another
strength is the substantial number of repeated measurements per
participant. In our opinion, these results are also rather general-
isable to other types of study populations, as it is unlikely that
the differences between sources in harmfulness would depend
on, for example, disease status. However, generalisability of the
results for the source category industry is more questionable
because the composition of emissions from industry depends
heavily on the type of industry. This may explain why, in con-
trast to our study, in a recent German study on the long-term
effects of air pollution on CRP an association with industry was
observed.35
One limitation of the study is that the source apportionment
was based on outdoor measurements instead of measurements
of actual exposures, which may cause source-dependent expos-
ure misclassification. Several studies have reported that daily
outdoor PM2.5, ABS and sulfate or sulfur (indicating LRT) cor-
relate longitudinally well with indoor concentrations and per-
sonal exposures.36–39 There is some evidence that outdoor
concentrations of PM2.5 from non-tailpipe emissions may not
reflect well the personal exposures.39 In general, there is very
little information on correlations between outdoor, indoor or
personal source-specific PM2.5 concentrations.
40 41 Strengths
and limitations of the source apportionment are discussed in the
online supplementary material.
An inherent limitation of systemic inflammation as an
outcome is caused by the fact that many factors influence short-
term changes in inflammation, such as exercise and stress. This
will add noise in the results and make associations between air
pollution and inflammation more difficult to observe. Moreover,
the role of CRP and FB as predictors of acute exacerbations of
heart diseases has been established, but the role of other inflam-
matory markers in this context is less clear.
CONCLUSION
Our results suggest that particulate air pollution from several
sources, including residential wood combustion and traffic, are
potential promoters of systemic inflammation, a risk factor for
cardiovascular diseases.
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